What's new

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Mar 3, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Senior management changes at Kia UK with new sales director

Next Article

Rush University System for Health to co-develop new feature for Epic

Related Posts

Human medicines European public assessment report (EPAR): Exforge, amlodipine,valsartan, Date of authorisation: 16/01/2007, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Training on human variations web-based electronic application form (eAF) functionalities for non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 February 2025, 10:30 (CET) to 11 February 2025, 12:30 (CET)

Training on human variations web-based electronic appli...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0